| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/21/2011 | CN101049157B Functional health food for preventing osteoporosis |
| 09/20/2011 | US8022187 Recombinant blood coagulation factor IX (rFIX) mutant having factor VIII (FVIII) independent factor X (FX) activation potential |
| 09/20/2011 | US8022174 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 09/20/2011 | US8021882 Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith |
| 09/20/2011 | US8021876 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 09/20/2011 | US8021869 Method of cell storage in a delivery system comprising a fibrous matrix |
| 09/20/2011 | US8021838 Transcriptional regulation of target genes |
| 09/20/2011 | US8021830 Method for increasing plasma volume by administering a plasma expander comprising basic alpha keratose |
| 09/20/2011 | US8021700 Topical skin salve and associated use therefor |
| 09/20/2011 | US8021693 Methods of organ regeneration using Hox11-expressing pluripotent cells |
| 09/20/2011 | US8021692 Graft materials containing bioactive substances, and methods for their manufacture |
| 09/20/2011 | US8021662 Microorganisms for therapy |
| 09/20/2011 | US8021658 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 09/20/2011 | US8021657 Isolated phages and their use in food or pet food products |
| 09/20/2011 | US8021656 Probiotics for gut neuromuscular functions |
| 09/20/2011 | US8021440 Method for the preparation of a carminic acid lake |
| 09/20/2011 | CA2693293C Method and bag set for concentrating white cells |
| 09/20/2011 | CA2573204C Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids |
| 09/20/2011 | CA2545470C Streptococcus phocae vaccine |
| 09/20/2011 | CA2510596C Dendritic cell line |
| 09/20/2011 | CA2482512C Improved viral purification methods |
| 09/20/2011 | CA2476619C Pet food composition for skin photoprotection |
| 09/20/2011 | CA2476477C Tissue specific expression |
| 09/20/2011 | CA2426348C Retrovirus isolated from humans |
| 09/20/2011 | CA2426334C Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/20/2011 | CA2410654C Method and device for concentrating and stabilizing conjugated estrogens from mares' urine |
| 09/20/2011 | CA2369848C Human endogenous retrovirus in breast cancer |
| 09/20/2011 | CA2347248C Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 09/20/2011 | CA2278208C Cell separation method |
| 09/20/2011 | CA2183542C Methods and compositions for stimulating bone cells |
| 09/15/2011 | WO2011112838A2 Composition and method for treatment of vascular hyperpermeability |
| 09/15/2011 | WO2011112822A2 Implantable therapeutic device and methods of making |
| 09/15/2011 | WO2011112421A2 Probiotic color cosmetic compositions and methods |
| 09/15/2011 | WO2011111914A1 Vascular endothelial progenitor cells introduced with haptoglobin gene, and composition containing same for promoting angiogenesis |
| 09/15/2011 | WO2011111824A1 Method for proliferating cardiomyocytes using micro-rna |
| 09/15/2011 | WO2011111787A1 Cell preparation containing mesenchymal stem cells, and method for producing same |
| 09/15/2011 | WO2011111783A1 Agent for controlling the increase and decrease of lactobacillus bifidus in colon |
| 09/15/2011 | WO2011111770A1 Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders |
| 09/15/2011 | WO2011111734A1 Lactic acid bacterium-containing preparation |
| 09/15/2011 | WO2011111588A1 Method of inducing the differentiation of germline stem cells, method of expanding the cells, and culture media therefor |
| 09/15/2011 | WO2011111392A1 Hjurp peptides and vaccines including the same |
| 09/15/2011 | WO2011110918A1 Composition comprising probiotic bacteria for use in the treatment of immune disorders |
| 09/15/2011 | WO2011110884A1 Lactic acid bacteria for coeliac disease |
| 09/15/2011 | WO2011062963A3 Induced puripotent stem cells and related methods |
| 09/15/2011 | WO2011060427A9 Composition and methods for affecting cytokines and nf-kb |
| 09/15/2011 | WO2011059836A3 T cell receptor-deficient t cell compositions |
| 09/15/2011 | WO2011057248A3 Methods of propagating monkey adenoviral vectors |
| 09/15/2011 | WO2011053653A3 Prevotella histicola preparations and the treatment of autoimmune conditions |
| 09/15/2011 | US20110225661 Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells |
| 09/15/2011 | US20110223262 Method of Enhancing Biological Activity of Plant Extracts |
| 09/15/2011 | US20110223253 Physically stabilized biodegradable osteochondral implant and methods for its manufacture and implantation |
| 09/15/2011 | US20110223251 Bacterial composition |
| 09/15/2011 | US20110223248 Methods and compositions for treating lactose intolerance |
| 09/15/2011 | US20110223209 Oxygen delivering scaffold for tissue engineering |
| 09/15/2011 | US20110223205 Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
| 09/15/2011 | US20110223153 Modified silk films containing glycerol |
| 09/15/2011 | US20110223146 Methods for preparation and use of marrow infiltratng lymphoctyes (mils) |
| 09/15/2011 | US20110223145 Immunosuppressive blood cells and methods of producing the same |
| 09/15/2011 | US20110223144 Creation of a Biological Atrioventricular Bypass to Compensate for Atrioventricular Block |
| 09/15/2011 | US20110223143 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same |
| 09/15/2011 | US20110223142 Methods and compositions for soft tissue repair |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223140 Method for differentiation into retinal cells from stem cells |
| 09/15/2011 | US20110223139 Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
| 09/15/2011 | US20110223138 Mesenchymal stem cells that express increased amounts of anti-apoptotic proteins |
| 09/15/2011 | US20110223137 Compositions for use in low-birth weight infants |
| 09/15/2011 | US20110223136 Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor |
| 09/15/2011 | US20110223135 SIMIAN ADENOVIRUSES SAdV-43, -45, -46, -47, -48, -49, AND -50 AND USES THEREOF |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | US20110223108 Glucagon-like peptide-2 and its therapeutic use |
| 09/15/2011 | CA2792910A1 Hjurp peptides and vaccines including the same |
| 09/15/2011 | CA2792802A1 Cell preparation containing mesenchymal stem cells, and method for producing same |
| 09/15/2011 | CA2792494A1 Yeast strains and their uses in the production of lipids |
| 09/15/2011 | CA2792411A1 Method for proliferating cardiomyocytes using micro-rna |
| 09/15/2011 | CA2792343A1 Composition comprising probiotic bacteria for use in the treatment of immune disorders |
| 09/15/2011 | CA2792085A1 Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders |
| 09/15/2011 | CA2791365A1 Probiotic color cosmetic compositions and methods |
| 09/15/2011 | CA2789533A1 Process, tube and device for the preparation of wound healant composition |
| 09/14/2011 | EP2365076A1 Artificial ubiquitous chromatin opening elements (ucoe) |
| 09/14/2011 | EP2365061A1 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same |
| 09/14/2011 | EP2364727A2 Molecular antigen array |
| 09/14/2011 | EP2364712A1 Topical cosmetic or pharmaceutical composition comprising probiotic lactobacillus strains and use of same |
| 09/14/2011 | EP2364711A1 Use of extracts from rabbit skin inflamed by vaccinia virus for the manufacture of a medicament for the treatment of acute cerebrovascular disease |
| 09/14/2011 | EP2364165A2 Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents |
| 09/14/2011 | EP2364156A2 Modified protozoan expressing at least two variable surface proteins (vsp), a vaccine comprising it and procedures, uses, and methods thereof |
| 09/14/2011 | EP2364155A1 Activation and aggregation of human platelets and formation of platelet gels by nanosecond pulsed electric fields |
| 09/14/2011 | EP1761635B1 Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 09/14/2011 | EP1599575B1 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| 09/14/2011 | EP1541674B9 Primary cultured adipocytes for gene therapy |
| 09/14/2011 | EP1405906B1 Schwann cells originating from bone marrow stromal cells |
| 09/14/2011 | EP1237582B1 Methods for introducing genes into mammalian subjects |
| 09/14/2011 | CN1954825B Supermicro Tongxinluo Chinese herbal composite and its new usage |
| 09/14/2011 | CN1903357B Liver hydrolytic peptide for injection and preparation method therefor |
| 09/14/2011 | CN1845988B Method for immunotherapy of tumors |
| 09/14/2011 | CN1436191B Antitumoral ecteinascidin derivatives |
| 09/14/2011 | CN102186971A Treatment of stroke using isolated placental cells |
| 09/14/2011 | CN102186494A Whey and thymus function |
| 09/14/2011 | CN102186486A Composition comprising a combination of an elder extract and a strain of l. paracasei, l. casei, l. bulgaricus or s. thermophilus |
| 09/14/2011 | CN102186485A Pharmaceutical composition for preventing and treating inflammatory diseases, containing an ethyl acetate fraction of dried extract of trachelospermi caulis as an active ingredient, and method for producing the fraction |
| 09/14/2011 | CN102181480A A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |